Managing Potential Drug Interactions of Nirmatrelvir/Ritonavir in COVID-19 Patients: A Perspective from an Israeli Cross-Sector Collaboration

Shiri Guy-Alfandary, Sasha Zhurat, Maya Berlin, Tal De Haan, Itai Gueta, Renata Shihmanter, Ahuva Golik, Matitiahu Berkovitch, Sara Eyal, Lee H. Goldstein*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

7 Scopus citations
Original languageAmerican English
Pages (from-to)1156-1158
Number of pages3
JournalClinical Pharmacology and Therapeutics
Volume112
Issue number6
DOIs
StatePublished - Dec 2022

Cite this